Mixtures of (phen)PdMe2 (2a) and HBAr‘4 (3a) or (phen)PdMe(Cl) (2b) and NaBAr‘4 (3b) [phen =
1,10-phenanthroline; Ar‘ = 3,5-C6H3(CF3)2] catalyzed the cyclization/hydrosilylation of functionalized
1,6-dienes to form silylated cyclopentanes in good yield and with excellent trans selectivity about
the newly formed C−C bond (typically >50:1). A range of tertiary hydrosilanes were employed in
the procedure although unhindered trialkylsilanes provided the most consistent results. The protocol
tolerated a range of polar functionality including esters, ethers, amides, sulfones, and cyano groups.
4,4-Disubstitution on the diene backbone promoted cyclization, and a homoallylic ester, ketone, or
ether directing group was required for efficient cyclization. The procedure tolerated dienes which
possessed a single trans-substituted olefin and also tolerated allylic substitution. These substituted
dienes underwent cyclization/hydrosilylation to form carbocycles resulting from transfer of the silyl
group to the less hindered olefin. Mixtures of 2a and 3a also catalyzed the cyclization/hydrosilylation
of functionalized 1,7-dienes to form silylated cyclohexane derivatives. Cyclization/hydrosilylation
of 1,7-dienes was typically slower, less stereoselective, and more sensitive to substitution than
was cyclization of 1,6-dienes.
A 1:1 mixture of the (π-allyl)palladium complex (η3-C3H5)Pd(Cl)PCy3 and NaB[3,5-C6H3(CF3)2]4 in the presence of HSiEt3 catalyzed the
cycloisomerization of functionalized 1,6-dienes to form 1,2-disubstituted cyclopentenes in good yield with high selectivity (typically >94%).
The protocol tolerated a range of functional groups and substitution at one of the allylic carbon atoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.